1. Home
  2. SSTK vs VNDA Comparison

SSTK vs VNDA Comparison

Compare SSTK & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shutterstock Inc.

SSTK

Shutterstock Inc.

N/A

Current Price

$16.74

Market Cap

534.9M

Sector

Technology

ML Signal

N/A

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

N/A

Current Price

$8.67

Market Cap

474.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SSTK
VNDA
Founded
2003
2002
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
534.9M
474.0M
IPO Year
2012
2005

Fundamental Metrics

Financial Performance
Metric
SSTK
VNDA
Price
$16.74
$8.67
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$25.00
$14.90
AVG Volume (30 Days)
419.5K
3.6M
Earning Date
05-20-2026
05-13-2026
Dividend Yield
8.22%
N/A
EPS Growth
23.76
N/A
EPS
1.25
N/A
Revenue
N/A
$216,105,000.00
Revenue This Year
$4.35
$21.50
Revenue Next Year
N/A
$38.67
P/E Ratio
$14.03
N/A
Revenue Growth
N/A
8.72
52 Week Low
$14.35
$3.81
52 Week High
$29.50
$9.60

Technical Indicators

Market Signals
Indicator
SSTK
VNDA
Relative Strength Index (RSI) 45.92 59.84
Support Level $14.36 $4.25
Resistance Level $20.07 $9.35
Average True Range (ATR) 0.98 0.56
MACD 0.20 0.09
Stochastic Oscillator 61.14 86.31

Price Performance

Historical Comparison
SSTK
VNDA

About SSTK Shutterstock Inc.

Shutterstock Inc is a U.S.-based company that is engaged in the provision of digital content. The content segment, whose offerings include licenses for Images, Footage, Music, 3 Dimensional, and Generative AI content. Data, Distribution, and Service offerings address customer demand for products and services that are beyond its Content licenses. The company generates the majority of its revenue from Content offerings. Geographically the company generates the majority of its revenue from the Domestic market, but also has its presence in Europe and Rest of the Countries.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: